BioSpace News Archive

Drug Development

RegeneRx Partner Signs LOI with Global Ophthalmology CRO for Two Phase 3 Clinical Trials in Neurotrophic Keratitis

RegeneRx Biopharmaceuticals, Inc. is reporting today that its U.S. joint venture (JV) partner and licensee, HLB Therapeutics (HLBT), has signed a letter of intent with a global ophthalmology contract research organization (CRO) to conduct two phase 3 clinical trials.

July 18, 2022
·
4 min read
Business

NSF Names Sean Etheridge Chief Legal Officer

NSF, a leading global public health and safety organization, today named Sean Etheridge its Chief Legal Officer.

July 18, 2022
·
2 min read
Lone Star Bio

Sonic Healthcare USA Announces Testing Availability for Monkeypox

This week, Sonic Healthcare USA (Sonic) began testing for Monkeypox (MPXV), using the Centers for Disease Control and Prevention (CDC) Non-variola Orthopoxvirus, high complexity NAAT (RT-PCR) molecular assay.

July 18, 2022
·
2 min read
BioCapital

Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio of Liquid Biopsy Tests

Delfi Diagnostics, Inc., a pioneering developer of a new class of high-performance, accessible liquid biopsy tests for early cancer detection and monitoring, today announced a Series B funding of $225 million.

July 18, 2022
·
3 min read
Biotech Beach

n-Lorem Foundation CEO Publishes Important Perspective in Nucleic Acid Research

n-Lorem, a nonprofit foundation, today announced the publication of an invited perspective article authored by n-Lorem founder and CEO, Dr. Stanley Crooke, and titled “Establishing an Environment in Which Rigorous Scientific Inquiry is Practiced”.

July 18, 2022
·
5 min read
Business

Johnson & Johnson’s Executive Vice President, General Counsel Michael Ullmann to Retire; Elizabeth Forminard Named General Counsel, Effective October 17, 2022

July 18, 2022 13:20 UTC Johnson & Johnson’s Executive Vice President, General Counsel Michael Ullmann to Retire; Elizabeth Forminard Named General Counsel, Effective October 17, 2022.

July 18, 2022
·
4 min read
BioHarvest Sciences Inc. Commences Trading on the OTCQB Market

BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”) ") is pleased to announce that its common shares are now trading on the OTCQB® Venture Market under the ticker symbol “CNVCF”.

July 18, 2022
·
3 min read
Business

Kevin DeGeeter Joins Nabsys as Chief Financial Officer

Nabsys, the pioneer in electronic whole-genome mapping, announced the appointment of Kevin DeGeeter as Chief Financial Officer.

July 18, 2022
·
3 min read
Business

Acera Surgical, Inc. Announces GPO Agreement with Capstone for its Synthetic Resorbable Hybrid-Scale Fiber Matrix, Restrata®

Acera Surgical, Inc. (Acera), a leading bioscience company developing and commercializing a portfolio of fully synthetic materials for regenerative medical applications, today announced it has entered a new phase of growth after signing an agreement with Capstone Health Alliance.

July 18, 2022
·
3 min read
Lone Star Bio

DuraStat Receives Vizient Innovative Technology Contract for Dural Repair Device

DuraStat LLC, a medical device company innovating in the area of surgical tissue closure, today announced it has received an Innovative Technology contract from Vizient, Inc. the nation’s largest member-driven health care performance improvement company.

July 18, 2022
·
2 min read